Stem Cells: Encouraging cartilage production
Recently watching a rerun of the 2016 Olympics gymnastics finals, I could not help marveling at the way the joints of the athletes could withstand so many gravity-defying leaps, twists, and landings. These feats are possible because the ends of our bones are covered by articular cartilage, a smooth tissue that allows fluid, pain-free movement. This tissue is made by specialized cells secreting proteins that trap water and form an extracellular matrix which cushions joints.
When articular cartilage wears away, for example in degenerative diseases such as osteoarthritis, movements become painful and quality of life drops severely. Yet, these conditions are increasingly common – in the United States alone, it is predicted that more than 78 million people could be affected by 2040 (Hootman et al., 2016).
Cartilage is not connected to the nervous system or to blood and lymphatic vessels, which means the tissue heals poorly when damaged. Most therapies for osteoarthritis therefore work by preserving the remaining cartilage or preventing further loss. Once the cartilage is lost, few interventions exist: surgeons can carefully damage the bone to promote the creation of new tissue, they can graft bone and cartilage obtained from a donor, or they can completely replace the joints with artificial ones (Steadman et al., 2001; Toh et al., 2014; Bugbee et al., 2016; Migliorini et al., 2020). However, these interventions may not be durable, and they are limited by factors such as the availability of donor tissue and the age or health condition of the patient.
Another, lab-based approach is to harvest mesenchymal stem cells or chondroprogenitor cells from patients, and then 'coax' these to create cartilage that can be implanted in the individual (Migliorini et al., 2020). However, one challenge associated with this method is the stability of the resulting cartilage: over time, it can change into bone, reducing the function of the repaired joint.
Long non-coding RNAs are molecules that regulate an array of genetic events in the cell, and it was reported recently that these sequences are essential to keep cartilage stable: for instance, several long non-coding RNAs are activated in mesenchymal stem cells that produce cartilage (Barter et al., 2017; Huynh et al., 2019). Now in eLife, Farshid Guilak and colleagues – including Nguyen Hyunh as first author – report having identified a long non-coding RNA called GRASLND which encourages mesenchymal stem cells to produce molecules that form cartilage (Huynh et al., 2020).
First, the team (which is based at Washington University in St. Louis, the St. Louis Shriners Hospital, Duke University and Vanderbilt University) designed RNA molecules that were used to deactivate GRASLND in mesenchymal stem cells. As a result, the production of cartilage decreased and these cells started to show a molecular profile associated with bone formation. These results demonstrate that, in these cells, GRASLND is required to maintain a cartilage-forming program (Figure 1).
Further experiments showed that GRASLND interacts with EIF2AK2, a kinase that normally inhibits a protein known as EIF2A, which triggers a molecular cascade called the type II IFN-γ signaling pathway (Samuel, 1979; Platanias, 2005). This pathway is essential for the immune system, but some of its elements, such as a cytokine called IFN-γ, also help to stimulate bone formation (Duque et al., 2011).
When GRASLND binds EIF2AK2, it probably stops this kinase from acting on EIF2A; this suppresses IFN activity while allowing the genes that promote the production of cartilage to be expressed (Figure 1B). On the other hand, Hyunh et al. find that removing GRASLND is associated with an increase in the expression of genes under the control of IFN-γ (Figure 1C). As IFN-γ promotes bone formation, these findings explain why depleting mesenchymal stem cells of GRASLND leads to more bone production.
Finally, Hyunh et al. used data mining to show that, in diseased cartilage, genes regulated by IFN are expressed more abundantly. This suggests that IFN-signaling may be directly responsible for the production of the abnormal, bony nodules that are often present in osteoarthritic cartilage.
Overall, these results indicate that — at least in vitro — GRASLND is an important modulator of type II IFN-γ signaling that is necessary for cartilage differentiation. They also highlight that this pathway may be involved in diseases of the cartilage. If so, the interaction between GRASLND and EIF2AK2 could be an important pharmacological target. Exploring this possibility will first require comparing the expression of GRASLND in healthy and diseased cartilage.
GRASLND has only been found in primates, but related long non-coding RNAs could be identified in other species by spotting the motifs that GRASLND needs to interact with EIF2AK2. In turn, this knowledge could pave the way for better animal models to study how this class of long non-coding RNAs is involved in degenerative joint diseases.
References
-
Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized miceJournal of Bone and Mineral Research 26:1472–1483.https://doi.org/10.1002/jbmr.350
-
Mechanisms of type-I- and type-II-interferon-mediated signallingNature Reviews Immunology 5:375–386.https://doi.org/10.1038/nri1604
-
Microfracture: surgical technique and rehabilitation to treat chondral defectsClinical Orthopaedics and Related Research 391:S362–S369.https://doi.org/10.1097/00003086-200110001-00033
-
Advances in mesenchymal stem cell-based strategies for cartilage repair and regenerationStem Cell Reviews and Reports 10:686–696.https://doi.org/10.1007/s12015-014-9526-z
Article and author information
Author details
Publication history
- Version of Record published: May 6, 2020 (version 1)
Copyright
© 2020, Stadler
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 864
- views
-
- 50
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Developmental Biology
- Stem Cells and Regenerative Medicine
Amniogenesis, a process critical for continuation of healthy pregnancy, is triggered in a collection of pluripotent epiblast cells as the human embryo implants. Previous studies have established that bone morphogenetic protein (BMP) signaling is a major driver of this lineage specifying process, but the downstream BMP-dependent transcriptional networks that lead to successful amniogenesis remain to be identified. This is, in part, due to the current lack of a robust and reproducible model system that enables mechanistic investigations exclusively into amniogenesis. Here, we developed an improved model of early amnion specification, using a human pluripotent stem cell-based platform in which the activation of BMP signaling is controlled and synchronous. Uniform amniogenesis is seen within 48 hr after BMP activation, and the resulting cells share transcriptomic characteristics with amnion cells of a gastrulating human embryo. Using detailed time-course transcriptomic analyses, we established a previously uncharacterized BMP-dependent amniotic transcriptional cascade, and identified markers that represent five distinct stages of amnion fate specification; the expression of selected markers was validated in early post-implantation macaque embryos. Moreover, a cohort of factors that could potentially control specific stages of amniogenesis was identified, including the transcription factor TFAP2A. Functionally, we determined that, once amniogenesis is triggered by the BMP pathway, TFAP2A controls the progression of amniogenesis. This work presents a temporally resolved transcriptomic resource for several previously uncharacterized amniogenesis states and demonstrates a critical intermediate role for TFAP2A during amnion fate specification.
-
- Stem Cells and Regenerative Medicine
A new mathematical model can estimate the number of precursor cells that contribute to regenerating blood cells in mice.